Table 6.
Analgesics under investigation in the pediatric population as agreed in a Pediatric Investigation Plan
| Pain conditiona | Analgesic | Age range |
|---|---|---|
| Acute pain | Fentanyl | Birth to <2 years (intravenous solution) 2 years to <18 years (plaster) |
| Morphine | Birth to <6 months | |
| Tapentadol | Birth to <18 years | |
| Paracetamol | Preterm to <28 days | |
| Chronic pain | Gabapentin | 3 months to <18 years |
| Tapentadol | Birth to <18 years | |
| Tanezumabb | 7–18 years | |
| Acute procedural pain | Glucose | Birth to <1 year |
| Methoxyflurane | 6 years to <18 years |
Notes: Data presented as a poster at 7th Congress of the European Academy of Paediatric Societies (EAPS 2018) Paris, France, October 30–November 3, 2018.91 aas given in the respective Pediatric Investigation Plan; b recent addition to original reference.